resonance susceptibilityweighted imaging (SWI) is a new, highlysensitive technique used to detect haemorrhage. This study evaluated the ability of magnetic resonance imaging (MRI) to detect haemorrhage in 45 lung cancer patients with brain metastases and compared the results with T2*-weighted imaging (T2*WI) and contrastenhanced T1-weighted imaging (CE-T1WI). Eighty-nine haemorrhagic brain metastases were identified in 31 patients using SWI, 68 were identified in 23 patients using T2*WI and 46 were identified in 14 patients using CE-T1WI. Most micro-bleeds could only be identified by SWI. It was concluded that haemorrhage is a frequent occurrence in brain metastases originating from lung cancer and that haemorrhage can be detected using SWI in a majority of brain metastases patients.
Introduction
Brain metastasis is a common and devastating neurological complication of lung cancer that is associated with major neurological disability; frequently, it is a reason for low survival rates and poor quality of life in affected patients. 1 Early diagnosis is important: research suggests that patients who have the best performance status, least neurological dysfunction and lowest subarachnoid tumour burden are more likely to respond to treatment and have prolonged survival, compared with patients who have greater disease burden. 2 Magnetic resonance imaging (MRI) is sensitive for the detection of brain metastases and contrast-enhanced T1-weighted imaging (CE-T1WI) is now considered to be the gold standard assessment method. 1 Contrast agents are widely used to check if cancer patients have brain metastases when they have no obvious symptoms of them and patients may be scanned by CE-T1WI several times.
The Food and Drug Administration (FDA) of the USA has suggested that gadolinium (Gd)-containing MRI contrast agents may be associated with the development of nephrogenic systemic fibrosis (NSF) and nephrogenic fibrosing dermopathy in patients with kidney failure. 3 The FDA has also stated that caution should be exercised in W Zhang, X-X Ma, Y-M Ji et al.
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administering Gd-containing contrast agents to patients who have moderately impaired or end-stage renal function. Until more is known about these potentially adverse effects, both physicians and patients must balance the benefits of using Gd-containing contrast agents against the risk of developing NSF. Many patients are cautious about receiving injections of MRI contrast agents and even refuse such procedures if they are not considered essential. However, without the use of contrast agents it becomes difficult to detect brain metastases in cancer patients who have no obvious symptoms of them.
Based on previously reported data it can be concluded that intracranial haemorrhage is common in brain metastases, particularly in lung cancer patients. 4, 5 However, as T2*-weighted imaging (T2*WI) and CE-T1WI are the most commonly used MRI techniques, it is likely that only lesions with obvious haemorrhage will be identified. This can result in a relatively low detection rate for brain metastases. 6 Susceptibility-weighted imaging (SWI) is a relatively new MRI technique that is a threedimensional, long-echo time (TE), fully velocity-compensated, gradient echo (GRE) sequence; this technique allows enhancement of local contrasts, exploiting the magnetic properties of tissues that affect magnetic field inhomogeneity. 7 -11 The SWI technique is exquisitely sensitive to most blood products, including deoxyhaemoglobin, methaemoglobin and haemosiderin, and can detect partially deoxygenated venous blood and different blood products in haemorrhages, even in micro-haemorrhages. Thus, SWI has been applied successfully to various neurological disorders including trauma, stroke, cerebral cavernous malformation, arteriovenous malformation and intratumoural haemorrhage. 8 SWI is proven to be more sensitive than conventional MRI in detecting haemorrhage, and the application of SWI makes it possible to detect brain metastases with small haemorrhages, without the use of contrast agents. 4, 5 The objective of this study was to evaluate the sensitivity of SWI at 3.0 T, compared with conventional MRI sequences (T2*WI and CE-T1WI) in detecting haemorrhagic brain metastases.
Patients and methods

PATIENTS
Lung cancer patients presenting at Qilu Hospital with brain metastases between January 2007 and June 2008 were included in this study. All patients first underwent conventional MRI examination and were diagnosed as having brain metastases secondary to lung cancer; SWI was performed within 1 week of study inclusion. Diagnosis was confirmed using histological methods, surgery and biopsy, or based on imaging findings.
The study protocol was approved by the Institutional Review Board of Qilu Hospital, Shandong University and all participants provided written informed consent.
DATA ACQUISITION
The MRI was performed using a 3.0 T MRI scanner (Signa ExciteII; GE Healthcare, Milwaukee, WI, USA) using a receiver-only eight-channel phased-array head coil for all acquisitions. Conventional MRI sequences were performed using normal procedures and included axial T1WI, T2*WI and threedimensional plane CE-T1WI. The SWI was obtained as a fully velocity-compensated three-dimensional GRE sequence using the following parameters: repletion time (TR)/TE, 24/11 ms; flip angle, 15º; matrix, 320 × 320; field of view, 220 × 220 mm; and slice thickness/spacing, 1.0/0 mm. Acquisition time was 6 min 28 s. The raw W Zhang, X-X Ma, Y-M Ji et al.
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complex k-space data sets were transferred to a workstation (ADW4.2; GE Healthcare) to perform post-processing work. Both magnitude and phase images were reconstructed from the raw data sets. A homodyne demodulation was used to correct variations. Next, a minimum intensity projection was performed to display the processed data by using contiguous 2-mm thick sections in the transverse plane in order to enhance the conspicuity of small veins and blood products in haemorrhagic foci.
IMAGING ANALYSIS
The MRI scans were independently reviewed by two experienced neuroradiologists. Haemorrhagic brain metastases were independently determined on T1WI, T2*WI and SWI scans for all cases, because serial evaluation of images from the same case could lead to potential bias. Haemorrhage was defined as a very low signal intensity area in the brain metastasis without continuity from surrounding vessel structures on T2*WI or SWI, and as a highintensity signal on T1WI. All brain metastases were confirmed using CE-T1WI.
STATISTICAL ANALYSIS
Numbers of haemorrhagic brain metastases were compared between SWI, T2*WI and T1WI using a two-sided Wilcoxon signed rank test. Statistical analyses were performed using the Statistical Package for the Social Sciences, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A P value < 0.05 was considered to be statistically significant.
Results
PATIENTS
In total, 45 lung cancer patients with bone metastases (29 males and 16 females; aged 31 -76 years) were included in this study. Diagnosis was mostly confirmed by histological methods involving surgery (16 cases) and biopsy (21 cases). In the remaining eight cases, diagnosis was based on imaging findings that showed metastases in other organs.
MRI OUTCOMES
Overall, 199 brain metastases were identified in the 45 patients using CE-T1WI. Within these metastases, 89 haemorrhages were detected in 31 patients (68.9%) using SWI (TR, 24 ms), 68 haemorrhages were detected in 23 patients (51.1%) using T2*WI (TR, 520 ms) and 46 haemorrhages were detected in 14 patients (31.1%) using T1WI (TR, 500 ms) ( Table 1 ). The corresponding haemorrhagic foci were unenhanced on CE-T1WI scans.
The 89 haemorrhagic brain metastases identified using SWI were classified into four types according to the shape of the haemorrhage (Table 1) ; different types of haemorrhagic metastases could appear in the same patient. Although there was no significant difference in the number of haemorrhages identified between the different MRI procedures, most of the nodular and focal haemorrhages were detected using at least one MRI technique other than SWI, whereas most of the ring-like haemorrhages and micro-bleeds were only detected using SWI. Brain metastases > 1 cm in diameter could be detected using both SWI and T2*WI, whereas it was difficult to detect those with diameter < 1 cm using T2*WI and none could be detected using T1W1 (Table 2) . Figure 1 shows a typical case of a 53-yearold man who underwent MRI 2.5 years after surgery for cancer of the left lung. Haemorrhagic foci in a cystic brain metastasis were identified using T2*WI and SWI. In this case, haemorrhage in a small brain metastasis was clearly shown using SWI but was hard to distinguish using T2*WI; it was confirmed using CE-T1WI. A W Zhang, X-X Ma, Y-M Ji et al.
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micro-bleed was only identified using SWI and was not enhanced by CE-T1WI.
Discussion
Use of MRI is currently considered to be the best imaging technique for evaluation of brain metastases and CE-T1WI is viewed as the gold standard. 1 Previously, T2*WI had been advocated as the most sensitive MRI technique to assess the number of haemorrhagic brain metastases, however brain metastases contain deoxyhaemoglobin or haemosiderin, which are likely to be related to blood stagnation and chronic micro-haemorrhages, and they result in a decrease in signal intensity with T2*WI. 6 The present study evaluated the sensitivity of SWI compared with T2*WI and T1WI in assessing the number of brain metastases with haemorrhagic foci in lung cancer patients. More haemorrhagic brain metastases were identified using SWI compared with T2*WI or T1WI; these were predominantly chronic micro-haemorrhages. The number of brain metastases detected using SWI was 1.93 and 1.31 times the number detected using T1WI and T2*WI, respectively. There was no statistically significant difference in the number of haemorrhages identified between the different MRI procedures. SWI, susceptibility-weighted imaging; T2*-weighted imaging (T2*WI); T1WI, T1-weighted imaging. There was no statistically significant difference in the number of haemorrhages identified between the different MRI procedures. SWI, susceptibility-weighted imaging; T2*-weighted imaging (T2*WI); T1WI, T1-weighted imaging.
MRI
TABLE 2: Number of brain haemorrhages identified in the brain metastases of lung cancer patients and numbers detected according their diameter and the magnetic resonance imaging (MRI) technique undertaken Detection of haemorrhage in brain metastases
One possible explanation for the higher sensitivity of SWI could be the improved detection of micro-haemorrhages compared with T2*WI and this result in the present study is consistent with previous comparative studies of the detection of haemorrhagic lesions using SWI and T2*WI. 5, 6, 11 Higher spatial resolution is acquired using SWI than with other MRI techniques, because SWI is based on thinner slices. 5,8 -11 In addition, the higher detectability of haemorrhages may be partly attributed to the relatively shorter TR used for SWI compared with T2*WI; the TR for T2*WI was 520 ms (considerably longer than the 24 ms used for SWI) and was necessary to obtain interleaved acquisitions with T2*WI. The shorter TR brought a greater T1-weighting effect to SWI, making white matter look bright and, consequently, showing the dark haemorrhage more prominently against the bright background of the brain.
Another reason for the higher sensitivity of SWI could be that the higher magnetic field of 3.0 T used in the present study led to superior brain metastases detection. Studies suggest that using a higher magnetic field of 3.0 T FIGURE 1: Typical case of a 53-yearold man who underwent magnetic resonance imaging (MRI) 2.5 years after surgery for cancer of the left lung. Haemorrhagic foci (black arrow) in a cystic brain metastasis were identified using (A) T2* weighted imaging (T2*WI) and (B) susceptibility-weighted imaging (SWI). Haemorrhage in a small brain metastasis (white arrow) was hard to distinguish using T2*WI (A), but was clearly visible using SWI (B). (C) Brain metastasis was confirmed using contrast T1-weighted imaging (CE-T1WI). A micro-bleed was only identified with SWI (white arrowhead) (B) and was not enhanced on CE-T1WI (C) (instead of 1.5 T) could potentially contribute to a higher image quality for both T2*WI and SWI through a higher signal-to-noise ratio, increased phase difference between different tissues, and decreased T2*. 11 In the 45 lung cancer patients with brain metastases, SWI detected 31 cases (68.9%) with haemorrhage (including micro-bleeds), hence over two-thirds of haemorrhagic brain metastases in these patients could be detected using SWI. This may potentially allow a reduction in the use of contrast agents in early-stage lung cancer patients, particularly in those with concomitant kidney failure.
In conclusion, the sensitivity of SWI in assigning the number of micro-bleeds in brain metastases appears to be higher than that of T2*WI. The SWI technique provides added diagnostic and therapeutic benefits and is likely to become incorporated into routine MRI assessment, with improvements in software technology allowing easier acquisition and interpretation. Given the current prevalence of 3.0 T MRI scanners and the better visibility of small haemorrhages using 3.0 T MRI, SWI should increasingly be applied in detecting brain metastases in early-stage lung cancer patients, particularly in those for whom the use of contrast agents is contraindicated, such as patients with kidney failure.
